Skip to main content
. 2018 Oct 9;123(3):429–438. doi: 10.1111/bju.14513

Figure 1.

Figure 1

The flow of patients through the study. (A) Patients with visible lesions on MRI 1. (B) Patients with no visible lesion on MRI 1. All 28 patients with visible lesions who did not have an initial confirmatory biopsy had small lesions with stable PSA and elected for PSA monitoring and repeat MRI before undergoing a biopsy. AS, active surveillance; Rx, treatment.